Final
Issued by: Health Resources and Services Administration (HRSA)
Recommended Uniform Screening Panel
The RUSP is a list of disorders that the Secretary of the Department of Health and Human Services (HHS) recommends for states to screen as part of their state universal newborn screening (NBS) programs.
Disorders on the RUSP are chosen based on evidence that supports the potential net benefit of screening, the ability of states to screen for the disorder, and the availability of effective treatments. It is recommended that every newborn be screened for all disorders on the RUSP.
Most states screen for the majority of disorders on the RUSP; newer conditions are still in process of adoption. Some states also screen for additional disorders.
Although states ultimately determine what disorders their NBS program will screen for, the RUSP establishes a standardized list of disorders that have been supported by the Advisory Committee on Heritable Disorders in Newborns and Children and recommended by the Secretary of HHS.
Conditions listed on the RUSP are part of the comprehensive preventive health guidelines supported by HRSA for infants and children under section 2713 of the Public Health Service Act. Non-grandfathered health plans are required to cover screenings included in the HRSA-supported comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years beginning on or after the date that is one year from the Secretary’s adoption of the condition for screening.
Previously Nominated Conditions (Recommended and Not Recommended for the RUSP)
Printer-Friendly Recommended Uniform Screening Panel (PDF - 95 KB)
Recommended Uniform Screening Panel1
Core2 Conditions3
(as of July 2018)
Core Condition |
Metabolic Disorder |
Endocrine Disorder |
Hemoglobin Disorder |
Other Disorder |
||
---|---|---|---|---|---|---|
Organic acid condition |
Fatty acid oxidation disorders |
Amino acid disorders |
||||
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
Spinal Muscular Atrophy due to homozygous deletion of exon 7 in SMN1 |
|
|
|
|
|
X |
- Selection of conditions based upon “Newborn Screening: Towards a Uniform Screening Panel and System.” Genetic Med. 2006; 8(5) Suppl: S12-S252” as authored by the American College of Medical Genetics (ACMG) and commissioned by the Health Resources and Services Administration (HRSA).
- Disorders that should be included in every Newborn Screening Program.
- Nomenclature for Conditions based upon “Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels.” Pediatrics. 2006; 117 (5) Suppl: S308-S314.
ACHDNC Recommended Uniform Screening Panel1
Secondary2 Conditions 3
(as of July 2018)
Secondary Condition |
Metabolic Disorder |
Hemoglobin Disorder |
Other Disorder |
||
---|---|---|---|---|---|
Organic acid condition |
Fatty acid oxidation disorders |
Amino acid disorders |
|||
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
Medium/short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency |
|
X |
|
|
|
|
X |
|
|
|
|
Medium-chain ketoacyl-CoA thiolase deficiency |
|
X |
|
|
|
2,4 Dienoyl-CoA reductase deficiency |
|
X |
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
Benign hyperphenylalaninemia |
|
|
X |
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
|
|
Various other hemoglobinopathies |
|
|
|
X |
|
|
|
|
|
X |
|
|
|
|
|
X |
|
T-cell related lymphocyte deficiencies |
|
|
|
|
X |
- Selection of conditions based upon “Newborn Screening: Towards a Uniform Screening Panel and System.” Genetic Med. 2006; 8(5) Suppl: S12-S252” as authored by the American College of Medical Genetics (ACMG) and commissioned by the Health Resources and Services Administration (HRSA).
- Disorders that can be detected in the differential diagnosis of a core disorder.
- Nomenclature for Conditions based upon “Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels.” Pediatrics. 2006; 117 (5) Suppl: S308-S314.
Persons using assistive technology may not be able to fully access information in this file. For assistance, please email Alaina Harris.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.